EFFECTS OF LOW DOSES OF KETAMINE ON INTRACRANIAL PRESSURE IN PATIENTS HAVING SPACE OCCUPYING LESION OF THE BRAIN

Main Article Content

Dr. Ravindra Sisodia
Dr. Shubham Khandelwal
Dr. Nisha Sharma
Dr. Vijay Mathur
Dr. Medha Bhardwaj
Dr. Sunita Sharma
Dr. Aishwarya Bajaj

Keywords

Ketamine, Optic nerve sheath diameter, Intracranial pressure, Supratentorial tumour, Neuroanaesthesia

Abstract

Background


Expansion of intracranial contents by a space-occupying lesion (SOL) leads to compression and distortion of the tissues of the CNS and can increase intracranial pressure(ICP). It was presumed that ketamine can cause a dangerous increase in ICP by increasing blood pressure. The present study was conducted to investigate the effects of low doses of ketamine on ICP in patients having space occupying lesion of the brain.


Methods


The study was conducted on 45 patients after obtaining approval from ethical committee. Patients included were posted for elective supratentorial surgeries for brain tumour excision. Standard induction was done intravenously in all patients with propofol, fentanyl and vecuronium with 5ml of normal saline (Group A), 0.25mg/kg ketamine diluted to 5ml (Group B), 0.5mg/kg ketamine diluted to 5ml (Group C). Optic nerve sheath diameter(ONSD) measurement by ocular sonography which serves as an indirect non-invasive technique to measure ICP was recorded at 3 instances i.e. before start of IV boluses of drugs, at 2 mins of bag and mask ventilation and at 5 mins of post endotracheal intubation.


Result


 ONSD values were comparable in all three groups at baseline. ONSD value decreased in all groups after 2 minutes of BMV and were comparable in all groups. Values slightly increased at 5 minutes after endotracheal intubation as compared to 2 minutes; though values were lesser than baseline in every group.


 


Conclusion


Our study refutes the old opinion that ketamine increases ICP. Combined with a benzodiazepine and barbiturates, ketamine may be the preferred sedative/anaesthetic agent for patients with space occupying lesion and can reduce ICP as well.

Abstract 246 | PDF Downloads 82

References

1. Rangel-Castilla L, Gopinath S, Robertson CS. Management of intracranial hypertension. Neurol Clin. 2008 May;26(2):521-41, x. doi: 10.1016/j.ncl.2008.02.003. Erratum in: Neurol Clin. 2008 Aug;26(3):xvii. Rangel-Castillo, Leonardo [corrected to Rangel-Castilla, Leonardo]. PMID: 18514825; PMCID: PMC2452989.
2. Habib A et al (2021). Effects of compressive lesions on intraoperative human spinal cord elasticity. 1. 100455. 10.1016/j.bas.2021.100455.
3. Tobias JD, Leder M. Procedural sedation: A review of sedative agents, monitoring, and management of complications. Saudi J Anaesth. 2011;5(4):395-410. doi:10.4103/1658-354X.87270
4. Mohd Raffiz, Jafri M. Abdullah, Optic nerve sheath diameter measurement: a means of detecting raised ICP in adult traumatic and non-traumatic neurosurgical patients, The American Journal of Emergency Medicine, Volume 35, Issue 1,2017,Pages 150-
153,https://doi.org/10.1016/j.ajem.2016.09.044.
5. Afshin Amini, Hamid Kariman, Ali Arhami Dolatabadi, Hamid Reza Hatamabadi, Hojjat Derakhshanfar, Behnam Mansouri, Saeed Safari, Razie Eqtesadi, Use of the sonographic diameter of optic nerve sheath to estimate intracranial pressure, The American Journal of Emergency Medicine, Volume 31, Issue 1,2013,Pages 236-239,ISSN 0735-6757,https://doi.org/10.1016/j.ajem.2012.06.025.
6. Goddard K, Sampson C, Bedy SM, Ghadban R, Stilley J. Effect of Ketamine on Cardiovascular Function During Procedural Sedation of Adults. Cureus. 2021;13(3):e14228. Published 2021 Mar 31. doi:10.7759/cureus.14228
7. Brown TC, Cole WH, Murray GH. Ketamine: A new anaesthetic agent. Australian and New Zealand Journal of Surgery. 1970 Feb;39(3):305-10.
8. Takeshita H, Okuda Y, Sari A. The effects of ketamine on cerebral circulation and metabolism in man. InThe Journal of the American Society of Anesthesiologists 1972 Jan 1 (Vol. 36, No. 1, pp. 69-75). The American Society of Anesthesiologists.
9. Dengler BA, Karam O, Barthol CA, Chance A, Snider LE, Mundy CM, Bounajem MT, Johnson WC, Maita MM, Mendez-Gomez PM, Seifi A. Ketamine boluses are associated with a reduction in intracranial pressure and an increase in cerebral perfusion pressure: A retrospective observational study of patients with severe traumatic brain injury. Critical care research and practice. 2022 May 21;2022.
10. Kishk NA, Ebraheim AM, Ashour AS, Badr NM, Eshra MA. Optic nerve sonographic examination to predict raised intracranial pressure in idiopathic intracranial hypertension: The cut-off points. Neuroradiol J. 2018 Oct;31(5):490-495. doi: 10.1177/1971400918789385. Epub 2018 Jul 19. PMID: 30024291; PMCID: PMC6136137.
11. Shirodkar CG, Rao SM, Mutkule DP, Harde YR, Venkategowda PM, Mahesh MU. Optic nerve sheath diameter as a marker for evaluation and prognostication of intracranial pressure in Indian patients: An observational study. Indian J Crit Care Med. 2014;18(11):728-734. doi:10.4103/0972-5229.144015
12. Tjaden RJ, Ethier R, Gilbert RG, et al. The use of CI-581 (Ketalar) for pediatric pneumoencephalography. J Can Assoc Radiol. 1969;20:155-156.
13. Evans J, Rosen M, Weeks RD, et al. Ketamine in neurosurgical procedures [letter]. Lancet. 1971;i:40-41. 3. Gardner AE, Olson BE, Lichtiger M. Cerebrospinal-fluid pressure during dissociative anesthesia with ketamine. Anesthesiology. 1971;35:226-228.
14. Gibbs JM. The effect of intravenous ketamine on cerebrospinal fluid pressure. Br J Anaesth. 1972;44:1298-1302. 5. List WF, Crumrine RS, Cascorbi HF, et al. Increased cerebrospinal fluid pressure after ketamine. Anesthesiology. 1972;36:98-99.
15. Lockhart CH, Jenkins JJ. Ketamine induced apnea in patients with increased intracranial pressure. Anesthesiology. 1972;37: 92-93.
16. Shapiro HM, Wyte SR, Harris AB. Ketamine anaesthesia in patients with intracranial pathology. Br J Anaesth. 1972;44:1200-1204.
17. Wyte SR, Shapiro HM, Turner P, et al. Ketamine-induced intracranial hypertension. Anesthesiology. 1972;36:174-176.
18. Crumrine RS, Nulsen FE, Weiss MH. Alterations in ventricular fluid pressure during ketamine anesthesia in hydrocephalic children. Anesthesiology. 1975;42:758-761
19. Green SM, Andolfatto G, Krauss BS. Ketamine and intracranial pressure: no contraindication except hydrocephalus. Annals of emergency medicine. 2015 Jan 1;65(1):52-4.
20. Bar-Joseph G, Guilburd Y, Tamir A, Guilburd JN. Effectiveness of ketamine in decreasing intracranial pressure in children with intracranial hypertension. J Neurosurg Pediatr. 2009 Jul;4(1):40-6. doi: 10.3171/2009.1.PEDS08319. PMID: 19569909.
21. Bourgoin A, Albanèse J, Léone M, Sampol-Manos E, Viviand X, Martin C. Effects of sufentanil or ketamine administered in target-controlled infusion on the cerebral hemodynamics of severely brain-injured patients. Critical care medicine. 2005 May 1;33(5):1109-13.
22. Cohen L, Athaide V, Wickham ME, Doyle-Waters MM, Rose NG, Hohl CM. The effect of ketamine on intracranial and cerebral perfusion pressure and health outcomes: a systematic review. Annals of emergency medicine. 2015 Jan 1;65(1):43-51.
23. Albanèse J, Arnaud S, Rey M, Thomachot L, Alliez B, Martin C. Ketamine decreases intracranial pressure and electroencephalographic activity in traumatic brain injury patients during propofol sedation. Anesthesiology. 1997 Dec;87(6):1328-34. doi: 10.1097/00000542-199712000-00011. PMID: 9416717.